IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$773M
AUM Growth
+$278M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1 +$33.1M
2 +$14.6M
3 +$14.3M
4
OLMA icon
Olema Pharmaceuticals
OLMA
+$13.5M
5
LLY icon
Eli Lilly
LLY
+$13.2M

Top Sells

1 +$53M
2 +$20.7M
3 +$16M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$11.8M

Sector Composition

1 Healthcare 99.47%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBX
176
MBX Biosciences
MBX
$1.41B
-48,071
ZBIO
177
Zenas BioPharma
ZBIO
$1.39B
0
UPB
178
Upstream Bio Inc
UPB
$422M
-161,113
PVLA
179
Palvella Therapeutics
PVLA
$1.6B
-64,746
MTSR
180
DELISTED
Metsera Inc
MTSR
0
TVRD
181
Tvardi Therapeutics
TVRD
$37.7M
0